The symptoms still happened, but they stopped running the show.
For the hundreds of thousands of women living with breast cancer in the UK, a cruel irony has long persisted: the very treatments that fight their disease also trigger severe menopausal symptoms, while the standard remedy for those symptoms remains forbidden to them. A clinical trial from Swansea University now offers a way through that gap — demonstrating that breast care nurses, trained in cognitive behavioral therapy, can meaningfully reduce hot flushes and night sweats, restoring quality of life without placing patients at further risk. The finding matters not only as a clinical advance but as a reminder that suffering which goes unaddressed long enough becomes invisible, and that sometimes the most powerful interventions are the ones that simply take a patient's distress seriously.
- Up to 85% of breast cancer patients face severe menopausal symptoms from their own treatment, yet hormone replacement therapy — the standard relief — is contraindicated, leaving women in a medically sanctioned void of care.
- Some women have stopped taking cancer-preventive medications entirely because the menopausal side effects became too unbearable to endure, turning a quality-of-life crisis into a direct threat to survival.
- A six-week program of nurse-delivered group CBT cut symptom frequency by over 28% — more than double the improvement seen with standard care — while also reducing anxiety, depression, and sleep disruption.
- The intervention's benefits persisted for months after sessions ended, and its delivery by trusted breast care nurses rather than specialists makes it scalable within existing healthcare relationships.
- A treatment manual and training course are already available through the British Menopause Society, meaning the infrastructure exists — what now stands between patients and relief is NHS capacity and institutional will.
Most women who undergo chemotherapy or hormone therapy for breast cancer encounter a side effect few are warned about: relentless hot flushes and night sweats, more severe and longer-lasting than those that come with natural menopause. Hormone replacement therapy, the conventional remedy, is off the table because it can raise the risk of recurrence. For years, women have lived inside that gap.
A clinical trial led by Swansea University and funded by Breast Cancer Now set out to close it. Involving 127 women across six UK hospitals, the study tested whether breast care nurses — trained by a clinical psychologist in cognitive behavioral therapy — could deliver meaningful relief through six weekly group sessions. The sessions covered stress management, paced breathing, sleep strategies, and techniques for navigating the physical and emotional weight of menopausal symptoms.
The results held. Women in the CBT group saw hot flush and night sweat frequency fall by more than 28 percent, compared to 11 percent in those receiving standard care. Symptoms became nearly twice as manageable. Sleep improved. Anxiety and depression declined. And the benefits lasted well beyond the final session.
The human stakes are made vivid by Natalie Richards, a 39-year-old mother of two diagnosed with triple negative breast cancer in 2019. Hot flushes struck every half hour, day and night. When she raised her distress with her medical team, she felt dismissed. Anxiety and depression followed. It took almost a year for the symptoms to ease — time she later reflected might have been transformed had her breast care nurse been equipped to help.
Her story echoes a wider pattern: some women have abandoned cancer-preventive therapies because the side effects became unlivable. The trial shows that trained nurses can not only reduce symptoms but help patients stay the course with their cancer care — a finding with consequences that extend well beyond comfort.
A treatment manual and training course are already available through the British Menopause Society. Breast Cancer Now has called on NHS Trusts to support implementation as health service pressures allow. The evidence is in place. For the 600,000 people living with breast cancer in the UK, what remains is the question of how quickly this reaches the women who need it.
Most women who undergo chemotherapy or hormone therapy for breast cancer will face a side effect that nobody warns them about: months of relentless hot flushes and night sweats. Up to 85 percent experience these symptoms, and they arrive with a particular cruelty—more severe and longer-lasting than the menopausal symptoms that come with age alone. The standard treatment for menopausal distress, hormone replacement therapy, is off the table for breast cancer patients because it can increase the risk of the disease returning. For years, women have endured this gap between what they need and what medicine can safely offer them.
A clinical trial led by researchers at Swansea University, funded by Breast Cancer Now, has found a way to close it. The study involved 127 women from six hospitals across the UK, all of whom had been diagnosed with breast cancer or ductal carcinoma in situ and were suffering from severe, frequent hot flushes or night sweats. Over six weeks, these women attended six 90-minute group sessions delivered by breast care nurses who had been specially trained by a clinical psychologist to teach cognitive behavioral therapy. The nurses covered stress management, paced breathing, sleep improvement, and specific techniques for managing the physical and emotional toll of hot flushes and night sweats.
The results were substantial. Women who received the nurse-delivered CBT reported that their symptoms became significantly less distressing and less problematic. The frequency of hot flushes and night sweats dropped by more than 28 percent—more than double the 11 percent reduction seen in women who received standard care and informal advice. Crucially, these improvements persisted for several months after the intervention ended. Beyond symptom reduction, the women reported that their night sweats and hot flushes became almost twice as manageable. Their sleep quality improved markedly, and levels of depression and anxiety declined.
The human weight of this finding becomes clear through the experience of Natalie Richards, a 39-year-old mother of two from London. Diagnosed with triple negative breast cancer in April 2019, she began chemotherapy and was blindsided by the intensity of her menopausal symptoms. Hot flushes came every half hour, day and night, drenching her in sweat regardless of the weather or time of day. Nobody had prepared her for this. When she mentioned her struggle to her medical team, she felt dismissed, offered no guidance on how to manage what was becoming an all-consuming crisis. She grew deeply anxious and depressed, embarrassed when the flushes struck in public. It took nearly a year before the symptoms eased. She later reflected that if her breast care nurse had been equipped to provide targeted support for these menopausal effects, it could have made an enormous difference.
Richards's experience points to a broader problem: some women with breast cancer have stopped their cancer-preventive treatments because the menopausal side effects became unbearable. The trial demonstrates that trained breast care nurses can deliver an intervention that not only reduces symptoms but helps women stay the course with their cancer care. Professor Myra Hunter from King's College London, who developed the group CBT protocol and trained the nurses in the trial, noted that previous research had shown this therapy effective when delivered by clinical psychologists. The step forward here is proving it works just as well when delivered by nurses—professionals the patients may already know and trust.
The pathway forward depends on NHS capacity. Breast Cancer Now has called for Trusts and Health Boards across the UK to support breast care nurses in delivering group CBT once pressures on the health service ease. A published treatment manual and training course are already available through the British Menopause Society, making the intervention accessible to health professionals who want to offer it. The research team has created the infrastructure for implementation; what remains is the will and the resources to roll it out. For the 600,000 people currently living with breast cancer in the UK, the question is not whether this works—the trial has answered that. The question now is how quickly it can reach the women who need it.
Citações Notáveis
If my breast care nurse had been equipped to provide targeted support for these menopausal effects, it could have made an enormous difference.— Natalie Richards, breast cancer patient
This therapy is just as effective when delivered by trained breast care nurses as when delivered by clinical psychologists.— Professor Myra Hunter, King's College London
A Conversa do Hearth Outra perspectiva sobre a história
Why does hormone replacement therapy get ruled out for breast cancer patients when it's the obvious answer for menopausal symptoms?
Because HRT contains hormones that can stimulate breast cancer cells to grow and divide. For women who've already had breast cancer, the risk of recurrence outweighs the comfort of symptom relief. It's a genuine bind—you solve one problem and create the possibility of a much worse one.
So CBT works here because it's not about hormones at all. It's about how you think about and respond to the symptoms?
Partly that, yes. But it's also practical—paced breathing, sleep strategies, stress management. The women in the trial didn't stop having hot flushes. They became less distressed by them, less consumed by them. The symptoms still happened, but they stopped running the show.
Why does it matter that nurses delivered it rather than psychologists?
Access, mainly. There aren't enough clinical psychologists to reach all the women who need this. But breast care nurses are already embedded in cancer care. They see these patients regularly. There's trust already there. And the trial proved the therapy doesn't lose its power just because it comes from a nurse instead of a specialist.
The fact that some women stop cancer treatment because of menopausal symptoms—that's the real stakes here, isn't it?
Exactly. You survive cancer, but then the side effects of your survival treatment become so unbearable that you abandon the very thing keeping you alive. That's the human cost nobody talks about. This intervention catches that gap.
What happens now? Does every breast cancer patient get offered this?
Not yet. The NHS is stretched. The researchers have made the manual and training available, but implementation depends on resources and capacity. It's a waiting game—the evidence is there, the tools exist, but the system has to find room for it.